• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生和前列腺炎对前列腺癌风险的协同作用。

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.

机构信息

Department of Emergency Medicine, Nantou Hospital, Nantou, Taiwan.

出版信息

Br J Cancer. 2013 May 14;108(9):1778-83. doi: 10.1038/bjc.2013.184. Epub 2013 Apr 23.

DOI:10.1038/bjc.2013.184
PMID:23612451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3658521/
Abstract

BACKGROUND

The incidence of prostate cancer is much lower in Asian men than in Western men. This study investigated whether prostate cancer is associated with prostatitis, benign prostatic hyperplasia (BPH), and other medical conditions in the low-incidence population.

METHODS

From the claims data obtained from the universal National Health Insurance of Taiwan, we identified 1184 patients with prostate cancer diagnosed from 1997 to 2008. Controls comprised 4736 men randomly selected from a cancer-free population. Both groups were 50 years of age or above. Medical histories between the two groups were compared.

RESULTS

Multivariate logistic regression analysis showed that prostatitis and BPH had stronger association with prostate cancer than the other medical conditions tested. Compared with men without prostatitis and BPH, a higher odds ratio (OR) for prostate cancer was associated with BPH (26.2, 95% confidence interval (CI) 20.8-33.0) than with prostatitis (10.5, 95% CI=3.36-32.7). Men with both conditions had an OR of 49.2 (95% CI=34.7-69.9).

CONCLUSION

Men with prostate cancer have strong association with prostatitis and/or BPH. Prostatitis interacts with BPH, resulting in higher estimated relative risk of prostate cancer in men suffering from both conditions.

摘要

背景

亚洲男性的前列腺癌发病率远低于西方男性。本研究旨在探讨在低发人群中,前列腺癌是否与前列腺炎、良性前列腺增生(BPH)和其他医疗状况相关。

方法

我们从台湾全民健康保险的理赔数据中,确定了 1997 年至 2008 年间诊断出的 1184 名前列腺癌患者。对照组由从无癌症人群中随机抽取的 4736 名男性组成。两组年龄均在 50 岁以上。比较两组之间的病史。

结果

多变量逻辑回归分析显示,前列腺炎和 BPH 与前列腺癌的相关性强于其他测试的医疗状况。与无前列腺炎和 BPH 的男性相比,BPH(26.2,95%置信区间[CI]20.8-33.0)与前列腺癌的比值比(OR)高于前列腺炎(10.5,95%CI=3.36-32.7)。同时患有这两种疾病的男性的 OR 为 49.2(95%CI=34.7-69.9)。

结论

患有前列腺癌的男性与前列腺炎和/或 BPH 有很强的相关性。前列腺炎与 BPH 相互作用,导致同时患有这两种疾病的男性前列腺癌的相对风险估计值更高。

相似文献

1
Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.良性前列腺增生和前列腺炎对前列腺癌风险的协同作用。
Br J Cancer. 2013 May 14;108(9):1778-83. doi: 10.1038/bjc.2013.184. Epub 2013 Apr 23.
2
Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men.在亚洲男性和高加索男性的尸检中,炎症和良性前列腺增生的流行情况。
Eur Urol. 2014 Oct;66(4):619-22. doi: 10.1016/j.eururo.2014.06.026. Epub 2014 Jul 8.
3
Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.慢性前列腺炎与良性前列腺增生症的相关性:基于人群的全国队列研究。
World J Urol. 2024 Mar 9;42(1):126. doi: 10.1007/s00345-024-04820-w.
4
Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.经计算的快速增长型良性前列腺增生——一种发生临床前列腺癌的风险因素。
Scand J Urol Nephrol. 2002;36(5):330-8. doi: 10.1080/003655902320783827.
5
Longitudinal association between prostatitis and development of benign prostatic hyperplasia.前列腺炎与良性前列腺增生症发生之间的纵向关联
Urology. 2008 Mar;71(3):475-9; discussion 479. doi: 10.1016/j.urology.2007.11.155.
6
High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.中东男性在无前列腺癌情况下血清前列腺特异性抗原水平升高:临床医生的困境
BJU Int. 2003 May;91(7):618-22. doi: 10.1046/j.1464-410x.2003.04199.x.
7
Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.无尿潴留表现的良性前列腺增生或前列腺腺癌男性患者中组织学前列腺炎的患病率
S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095.
8
Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).患有前列腺异常(前列腺癌/良性前列腺增生/前列腺炎)的男性体内前列腺特异性抗原自身抗体的存在情况。
Andrologia. 2015 Apr;47(3):328-32. doi: 10.1111/and.12265. Epub 2014 Mar 12.
9
Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.二甲双胍可降低良性前列腺增生男性的前列腺癌风险:一项全国性基于人群的队列研究。
Cancer Med. 2019 May;8(5):2514-2523. doi: 10.1002/cam4.2025. Epub 2019 Apr 9.
10
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.良性前列腺增生(BPH)与前列腺炎:临床诊断为BPH的男性中射精疼痛的患病率
BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x.

引用本文的文献

1
Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients' populations.前列腺炎、良性前列腺增生和前列腺癌:一项双向孟德尔随机化研究及其对这些患者群体的临床意义。
Biol Direct. 2024 Dec 19;19(1):129. doi: 10.1186/s13062-024-00575-x.
2
Associations between inflammatory burden index, prostate cancer, and mortality among middle-aged and elderly individuals.炎症负担指数与中老年人群前列腺癌及死亡率的相关性。
World J Urol. 2024 Sep 26;42(1):538. doi: 10.1007/s00345-024-05241-5.
3
Genetically predicted alterations in thyroid function are associated with the risk of benign prostatic disease.遗传预测的甲状腺功能改变与良性前列腺疾病的风险相关。
Front Endocrinol (Lausanne). 2023 Apr 17;14:1163586. doi: 10.3389/fendo.2023.1163586. eCollection 2023.
4
The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study.前列腺炎与前列腺癌风险的关联:一项基于国家健康保险数据库的研究。
World J Urol. 2022 Nov;40(11):2781-2787. doi: 10.1007/s00345-022-04165-2. Epub 2022 Oct 6.
5
Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer.前列腺疾病中SPC24的增加以及SPC24及其相互作用蛋白在前列腺癌中的诊断价值
Exp Ther Med. 2021 Sep;22(3):923. doi: 10.3892/etm.2021.10355. Epub 2021 Jun 30.
6
Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms.睾酮替代治疗与下尿路症状之间的相关性
Int Neurourol J. 2021 Mar;25(1):12-22. doi: 10.5213/inj.2040234.117. Epub 2021 Jan 19.
7
Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients.良性前列腺增生和/或前列腺炎对韩国患者前列腺癌风险的影响。
World J Mens Health. 2021 Apr;39(2):358-365. doi: 10.5534/wjmh.190135. Epub 2020 Feb 5.
8
Association of Cholecystectomy with the Risk of Prostate Cancer in Patients with Gallstones.胆囊切除术与胆结石患者前列腺癌风险的关联
Cancers (Basel). 2020 Feb 27;12(3):544. doi: 10.3390/cancers12030544.
9
Case-control study examining the association between hip fracture risk and statins therapy in old people.一项病例对照研究,探讨老年人髋部骨折风险与他汀类药物治疗之间的关联。
Medicine (Baltimore). 2019 Oct;98(41):e17476. doi: 10.1097/MD.0000000000017476.
10
The incidence, mortality, and risk factors of prostate cancer in Asian men.亚洲男性前列腺癌的发病率、死亡率及风险因素。
Prostate Int. 2019 Mar;7(1):1-8. doi: 10.1016/j.prnil.2018.11.001. Epub 2018 Nov 22.

本文引用的文献

1
Is there a link between BPH and prostate cancer?良性前列腺增生与前列腺癌之间存在关联吗?
Practitioner. 2012 Apr;256(1750):13-6, 2.
2
Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.在患有尿潴留和前列腺良性增生或前列腺腺癌的患者中,组织学前列腺炎的意义。
BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18.
3
A large cohort study of long-term acetaminophen use and prostate cancer incidence.一项关于长期使用对乙酰氨基酚与前列腺癌发病率的大型队列研究。
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1322-8. doi: 10.1158/1055-9965.EPI-11-0210. Epub 2011 May 17.
4
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.良性前列腺增生症和前列腺癌的症状关联:前列腺癌预防试验的结果。
Am J Epidemiol. 2011 Jun 15;173(12):1419-28. doi: 10.1093/aje/kwq493. Epub 2011 May 3.
5
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.良性前列腺增生症与前列腺癌之间的争议性关系:炎症的作用。
Eur Urol. 2011 Jul;60(1):106-17. doi: 10.1016/j.eururo.2011.03.055. Epub 2011 Apr 9.
6
Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.良性前列腺增生:治疗模式和前列腺癌患病率的种族差异。
BJU Int. 2011 Oct;108(8):1302-8. doi: 10.1111/j.1464-410X.2010.09991.x. Epub 2011 Mar 4.
7
Diabetes and risk of prostate cancer: a study using the National Health Insurance.糖尿病与前列腺癌风险:基于国民健康保险的研究。
Diabetes Care. 2011 Mar;34(3):616-21. doi: 10.2337/dc10-1640. Epub 2011 Jan 27.
8
Metabolic syndrome and urologic diseases.代谢综合征与泌尿系统疾病
Rev Urol. 2010 Fall;12(4):e157-80.
9
Prostate cancer as incidental finding in transurethral resection.经尿道前列腺切除术中偶然发现的前列腺癌。
Arch Esp Urol. 2010 Dec;63(10):855-61.
10
Prostate cancer incidence and mortality trends in 37 European countries: an overview.37 个欧洲国家的前列腺癌发病率和死亡率趋势:概述。
Eur J Cancer. 2010 Nov;46(17):3040-52. doi: 10.1016/j.ejca.2010.09.013.